In a move that may greatly expand the detection and treatment of Barrett’s esophagus, a new American Gastroenterological Association Clinical Practice Update suggests that patients without chronic reflux symptoms should be considered for BE/esophageal cancer screening. An important advance from this document is the emphasis on using risk factors outside of gastroesophageal reflux disease when considering which patients should undergo screening.
“We want to be thoughtful as we roll